These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 27189318)

  • 1. Association of Urinary Biomarkers of Inflammation, Injury, and Fibrosis with Renal Function Decline: The ACCORD Trial.
    Nadkarni GN; Rao V; Ismail-Beigi F; Fonseca VA; Shah SV; Simonson MS; Cantley L; Devarajan P; Parikh CR; Coca SG
    Clin J Am Soc Nephrol; 2016 Aug; 11(8):1343-1352. PubMed ID: 27189318
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Urine Markers of Kidney Tubule Cell Injury and Kidney Function Decline in SPRINT Trial Participants with CKD.
    Malhotra R; Katz R; Jotwani V; Ambrosius WT; Raphael KL; Haley W; Rastogi A; Cheung AK; Freedman BI; Punzi H; Rocco MV; Ix JH; Shlipak MG
    Clin J Am Soc Nephrol; 2020 Mar; 15(3):349-358. PubMed ID: 32111704
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Kidney Damage Biomarkers and Incident Chronic Kidney Disease During Blood Pressure Reduction: A Case-Control Study.
    Zhang WR; Craven TE; Malhotra R; Cheung AK; Chonchol M; Drawz P; Sarnak MJ; Parikh CR; Shlipak MG; Ix JH;
    Ann Intern Med; 2018 Nov; 169(9):610-618. PubMed ID: 30357395
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Urine Biomarkers of Kidney Tubule Health, Injury, and Inflammation are Associated with Progression of CKD in Children.
    Greenberg JH; Abraham AG; Xu Y; Schelling JR; Feldman HI; Sabbisetti VS; Ix JH; Jogalekar MP; Coca S; Waikar SS; Shlipak MG; Warady BA; Vasan RS; Kimmel PL; Bonventre JV; Denburg M; Parikh CR; Furth S; ;
    J Am Soc Nephrol; 2021 Oct; 32(10):2664-2677. PubMed ID: 34544821
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Associations of Plasma Biomarkers of Inflammation, Fibrosis, and Kidney Tubular Injury With Progression of Diabetic Kidney Disease: A Cohort Study.
    Gutiérrez OM; Shlipak MG; Katz R; Waikar SS; Greenberg JH; Schrauben SJ; Coca S; Parikh CR; Vasan RS; Feldman HI; Kimmel PL; Cushman M; Bonventre JV; Sarnak MJ; Ix JH
    Am J Kidney Dis; 2022 Jun; 79(6):849-857.e1. PubMed ID: 34752914
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Urinary epidermal growth factor, monocyte chemoattractant protein-1 or their ratio as predictors for rapid loss of renal function in type 2 diabetic patients with diabetic kidney disease.
    Satirapoj B; Dispan R; Radinahamed P; Kitiyakara C
    BMC Nephrol; 2018 Sep; 19(1):246. PubMed ID: 30241508
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Markers of early progressive renal decline in type 2 diabetes suggest different implications for etiological studies and prognostic tests development.
    Nowak N; Skupien J; Smiles AM; Yamanouchi M; Niewczas MA; Galecki AT; Duffin KL; Breyer MD; Pullen N; Bonventre JV; Krolewski AS
    Kidney Int; 2018 May; 93(5):1198-1206. PubMed ID: 29398132
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of urinary monocyte chemoattractant protein-1 (MCP-1) and kidney injury molecule-1 (KIM-1) with risk factors of diabetic kidney disease in type 2 diabetes patients.
    Siddiqui K; Joy SS; Al-Rubeaan K
    Int Urol Nephrol; 2019 Aug; 51(8):1379-1386. PubMed ID: 31250339
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sodium Bicarbonate Supplementation and Urinary TGF-
    Raphael KL; Greene T; Wei G; Bullshoe T; Tuttle K; Cheung AK; Beddhu S
    Clin J Am Soc Nephrol; 2020 Feb; 15(2):200-208. PubMed ID: 31974286
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Kidney Biomarkers and Decline in eGFR in Patients with Type 2 Diabetes.
    Garlo KG; White WB; Bakris GL; Zannad F; Wilson CA; Kupfer S; Vaduganathan M; Morrow DA; Cannon CP; Charytan DM
    Clin J Am Soc Nephrol; 2018 Mar; 13(3):398-405. PubMed ID: 29339356
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Urinary monocyte chemotactic protein 1: marker of renal function decline in diabetic and nondiabetic proteinuric renal disease.
    Camilla R; Brachemi S; Pichette V; Cartier P; Laforest-Renald A; MacRae T; Madore F; Troyanov S
    J Nephrol; 2011; 24(1):60-7. PubMed ID: 20437404
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Measuring urinary tubular biomarkers in type 2 diabetes does not add prognostic value beyond established risk factors.
    Conway BR; Manoharan D; Manoharan D; Jenks S; Dear JW; McLachlan S; Strachan MW; Price JF
    Kidney Int; 2012 Oct; 82(7):812-8. PubMed ID: 22718188
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Changes in tubular biomarkers with dietary intervention and metformin in patients with autosomal dominant polycystic kidney disease: a post-hoc analysis of two clinical trials.
    Wang W; You Z; Steele CN; Gitomer B; Chonchol M; Nowak KL
    BMC Nephrol; 2024 Jun; 25(1):206. PubMed ID: 38918734
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of Urine Biomarkers of Kidney Tubule Injury and Dysfunction With Frailty Index and Cognitive Function in Persons With CKD in SPRINT.
    Miller LM; Rifkin D; Lee AK; Kurella Tamura M; Pajewski NM; Weiner DE; Al-Rousan T; Shlipak M; Ix JH
    Am J Kidney Dis; 2021 Oct; 78(4):530-540.e1. PubMed ID: 33647393
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Associations of urinary epidermal growth factor and monocyte chemotactic protein-1 with kidney involvement in patients with diabetic kidney disease.
    Wu L; Li XQ; Chang DY; Zhang H; Li JJ; Wu SL; Zhang LX; Chen M; Zhao MH
    Nephrol Dial Transplant; 2020 Feb; 35(2):291-297. PubMed ID: 30357416
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of Multiple Plasma Biomarker Concentrations with Progression of Prevalent Diabetic Kidney Disease: Findings from the Chronic Renal Insufficiency Cohort (CRIC) Study.
    Schrauben SJ; Shou H; Zhang X; Anderson AH; Bonventre JV; Chen J; Coca S; Furth SL; Greenberg JH; Gutierrez OM; Ix JH; Lash JP; Parikh CR; Rebholz CM; Sabbisetti V; Sarnak MJ; Shlipak MG; Waikar SS; Kimmel PL; Vasan RS; Feldman HI; Schelling JR;
    J Am Soc Nephrol; 2021 Jan; 32(1):115-126. PubMed ID: 33122288
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A panel of novel biomarkers representing different disease pathways improves prediction of renal function decline in type 2 diabetes.
    Pena MJ; Heinzel A; Heinze G; Alkhalaf A; Bakker SJ; Nguyen TQ; Goldschmeding R; Bilo HJ; Perco P; Mayer B; de Zeeuw D; Lambers Heerspink HJ
    PLoS One; 2015; 10(5):e0120995. PubMed ID: 25973922
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biomarkers of inflammation and repair in kidney disease progression.
    Puthumana J; Thiessen-Philbrook H; Xu L; Coca SG; Garg AX; Himmelfarb J; Bhatraju PK; Ikizler TA; Siew ED; Ware LB; Liu KD; Go AS; Kaufman JS; Kimmel PL; Chinchilli VM; Cantley LG; Parikh CR
    J Clin Invest; 2021 Feb; 131(3):. PubMed ID: 33290282
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Markers of Glomerular and Tubular Damage in the Early Stage of Kidney Disease in Type 2 Diabetic Patients.
    Żyłka A; Dumnicka P; Kuśnierz-Cabala B; Gala-Błądzińska A; Ceranowicz P; Kucharz J; Ząbek-Adamska A; Maziarz B; Drożdż R; Kuźniewski M
    Mediators Inflamm; 2018; 2018():7659243. PubMed ID: 30158836
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Urinary Biomarkers of Tubular Health and Risk for Kidney Function Decline or Mortality in Diabetes.
    Chen TK; Coca SG; Thiessen-Philbrook HR; Heerspink HJL; Obeid W; Ix JH; Fried LF; Bonventre JV; El-Khoury JM; Shlipak MG; Parikh CR;
    Am J Nephrol; 2022; 53(11-12):775-785. PubMed ID: 36630924
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.